4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for complete information.
4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6 Product Information
4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-T-99715.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6
CAT No.
CS-T-99715
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
13C6H2Cl4O4S2
Molecular Weight
349.98
Category
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for complete information.
Description
Regulatory Description
4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6 is supplied with detailed characterization data compliant with regulatory guideline. 4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6 can be used for analytical method development, method validation (AMV), Quality Control (QC), ANDA-related analytical work, and commercial pharmaceutical research applications.
Overview
"4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6 is an intermediate used in the synthesis of Diclofenamide-13C6 (D436532), which is the labeled form of Diclofenamide, a potent carbonic anhydrase inhibitor. Diclofenamide may provide a therapeutic strategy in the inhibition of the human cytosolic isoforms I and II and transmembrane tumor-associated isoenzymes IX and XII. Diclofenamide has been shown to be is effective in the prevention of episodic weakness in both hypokalemic periodic paralysis (HypoPP) and potassium-sensitive periodic paralysis (PSPP)."
Synonyms
4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6
Application Notes
"4,5-Dichloro-1,3-benzenedisulfonyl Dichloride-13C6 is an intermediate used in the synthesis of Diclofenamide-13C6 (D436532), which is the labeled form of Diclofenamide, a potent carbonic anhydrase inhibitor. Diclofenamide may provide a therapeutic strategy in the inhibition of the human cytosolic isoforms I and II and transmembrane tumor-associated isoenzymes IX and XII. Diclofenamide has been shown to be is effective in the prevention of episodic weakness in both hypokalemic periodic paralysis (HypoPP) and potassium-sensitive periodic paralysis (PSPP)."
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.